Buy Prescription Weight Loss Pens Online UK | Cured

Clinically Proven UK Registered Pharmacy

Buy Prescription Weight Loss Pens Online UK

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW 10 % off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £135.00 10% discount using discount code WEIGHTLOSSNEW
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen - UK-licensed prescription Treatment
Treatment

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

From £145.00

Future orders save 5%
Start Assessment
Wegovy (Semaglutide) Weight Loss Injection - UK-licensed prescription Treatment
Treatment

Wegovy (Semaglutide) Weight Loss Injection

From £89.00

Future orders save 5%
Start Assessment
Saxenda - UK-licensed prescription Treatment
Treatment

Saxenda

From £68.00

Future orders save 5%
Start Assessment
Orlistat - UK-licensed prescription Treatment
Treatment

Orlistat

From £32.00

Future orders save 5%
Start Assessment
Xenical Orlistat 120mg Capsules - UK-licensed prescription Treatment
Treatment

Xenical Orlistat 120mg Capsules

From £49.99

Future orders save 5%
Start Assessment
Alli Weight Loss Capsules 60mg - UK-licensed prescription Treatment
Treatment

Alli Weight Loss Capsules 60mg

From £49.99

Future orders save 5%
Start Assessment

Buy Prescription Weight Loss Pens Online UK

Published on: June 03, 2026

When you buy prescription weight loss pens online UK through Cured Pharmacy, you access the latest MHRA-licensed GLP-1 treatments with transparent pricing from £135.00 free clinical consultations under three minutes, and discreet home delivery. Our UK-registered prescribers assess every patient individually to determine the most appropriate treatment based on your medical history and weight loss goals.

How GLP-1 Weight Loss Injection Pens Work

Prescription weight loss pens contain GLP-1 receptor agonists or dual GIP/GLP-1 agonists—medications that mimic natural gut hormones to regulate appetite, slow gastric emptying, and improve insulin sensitivity [1]. These once-weekly or daily injections work at the hormonal level rather than simply suppressing appetite mechanically.

The most advanced option, Mounjaro (tirzepatide), activates both GIP and GLP-1 pathways simultaneously. In the SURMOUNT-1 trial, participants achieved an average weight reduction of 20.9% over 72 weeks on the 15mg maintenance dose—the highest efficacy seen in any obesity medication trial to date [1]. Wegovy (semaglutide) demonstrated 14.9% average weight loss in the STEP-1 trial, whilst Saxenda (liraglutide) produced 8% average reduction in the SCALE trial [2][3].

All three medications are licensed by the MHRA specifically for chronic weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities such as type 2 diabetes or hypertension. They require ongoing clinical supervision and work best when combined with dietary modification and increased physical activity.

Comparing Mounjaro, Wegovy, and Saxenda Injection Pens

Mounjaro contains tirzepatide, the UK's first dual GIP/GLP-1 receptor agonist, offering superior weight loss outcomes compared to single-pathway treatments. Clinical trials show tirzepatide produces approximately 40% greater weight reduction than semaglutide at comparable timeframes [1][2]. The once-weekly injection schedule and pre-filled KwikPen design make administration straightforward.

Wegovy delivers semaglutide in escalating doses up to 2.4mg weekly. It's well-established with extensive real-world data across UK patients and demonstrates consistent efficacy for those who maintain treatment adherence. The injection pen uses a simple push-button mechanism suitable for self-administration at home.

Saxenda requires daily injections of liraglutide, which some patients find less convenient but others prefer for more granular dose control. The lower per-pen cost makes it an accessible entry point for patients new to GLP-1 therapy, though the daily commitment requires consistent routine.

Which Weight Loss Pen Suits Your Needs?

Your UK prescriber will assess multiple factors including your BMI, medical history, concurrent medications, previous weight loss attempts, and lifestyle when recommending treatment. Patients with type 2 diabetes often benefit from Mounjaro's dual mechanism, whilst those preferring once-weekly administration may favour either Mounjaro or Wegovy over daily Saxenda.

Side effect profiles differ slightly—tirzepatide and semaglutide commonly cause transient nausea, diarrhoea, and constipation during dose escalation, which typically resolve within 4-8 weeks [1][2]. Liraglutide's daily dosing may produce milder gastrointestinal effects for some patients. All three medications carry similar contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Clinical Evidence Behind Weight Loss Injection Pens

The SURMOUNT-1 trial enrolled 2,539 adults without diabetes, demonstrating that tirzepatide 15mg produced average weight loss of 20.9% compared to 3.1% with placebo over 72 weeks [1]. Importantly, 91% of participants on the highest dose achieved at least 5% weight loss—the threshold associated with meaningful cardiometabolic benefits—and 57% achieved ≥20% reduction.

Semaglutide's efficacy was established in the STEP trial programme. STEP-1 showed 14.9% average weight loss with semaglutide 2.4mg versus 2.4% with placebo at 68 weeks [2]. The STEP-2 trial specifically examined patients with type 2 diabetes, showing 9.6% average reduction—demonstrating effectiveness across different patient populations.

Long-term data from the SCALE Obesity and Prediabetes trial showed liraglutide 3mg produced 8.0% average weight loss versus 2.6% with placebo at 56 weeks [3]. Whilst numerically lower than newer agents, liraglutide's longer UK market presence provides extensive real-world safety data spanning nearly a decade of clinical use.

Understanding Trial Data in Real-World Context

Clinical trial results represent average outcomes under controlled conditions with high adherence rates and regular monitoring. Individual responses vary considerably—some patients exceed average weight loss whilst others experience more modest reductions. Factors including baseline weight, dietary adherence, physical activity levels, sleep quality, stress management, and concurrent medications all influence outcomes.

The most successful patients typically combine medication with structured lifestyle modification. NICE guidelines recommend GLP-1 treatments as part of comprehensive weight management programmes rather than standalone interventions [4]. Your UK prescriber will discuss realistic expectations based on your individual circumstances during the consultation process.

Treatment Active Ingredient Frequency Average Weight Loss Starting Price
Mounjaro Tirzepatide (dual GIP/GLP-1) Once weekly Up to 20.9% (72 weeks) From £124.99
Wegovy Semaglutide (GLP-1) Once weekly Up to 14.9% (68 weeks) From £69.00
Saxenda Liraglutide (GLP-1) Daily injection Up to 8.0% (56 weeks) From £68.00

How to Buy Prescription Weight Loss Pens Online Safely

Legitimate UK online pharmacies must be registered with the General Pharmaceutical Council (GPhC) and display their registration number prominently. Cured Pharmacy operates under GPhC registration 9012511 with superintendent pharmacist Tarun Kumar (GPhC 2233073) providing clinical oversight. Every prescription medication requires assessment by a UK-registered prescriber before dispensing.

The online consultation process takes under three minutes and collects essential medical information including current medications, allergies, cardiovascular history, thyroid conditions, and previous weight loss attempts. A UK prescriber reviews your responses, and if appropriate, issues a prescription electronically to our pharmacy team for dispensing and discreet delivery.

Beware of websites offering prescription-only medications without clinical assessment, claiming to source medications from non-UK suppliers, or advertising prices significantly below market rates for genuine branded products. Counterfeit weight loss injections pose serious health risks including incorrect active ingredients, bacterial contamination, or improper storage compromising medication stability.

Starting Treatment: What to Expect with Weight Loss Pens

All three medications follow dose escalation protocols to minimise gastrointestinal side effects. Mounjaro starts at 2.5mg weekly for four weeks, increasing to 5mg, then potentially to 7.5mg, 10mg, 12.5mg, or 15mg based on tolerability and response [1]. Wegovy escalates monthly from 0.25mg to the maintenance dose of 2.4mg over 16-20 weeks [2]. Saxenda increases daily from 0.6mg to 3mg over five weeks [3].

Most patients notice appetite reduction within the first week, though significant weight loss typically becomes apparent after 8-12 weeks once maintenance doses are reached. Gastrointestinal side effects—nausea, occasional vomiting, diarrhoea, or constipation—are most common during dose increases and usually resolve as your body adapts. Taking the injection after meals, staying well-hydrated, and eating smaller portions help manage these effects.

Injections are administered subcutaneously into the abdomen, thigh, or upper arm using pre-filled pens with fine needles (4-8mm). Most patients report minimal discomfort—comparable to a small pinch. Rotating injection sites reduces the risk of lipohypertrophy (fatty lumps under the skin). Your medication arrives with detailed administration instructions and our pharmacy team remains available for guidance.

Monitoring Progress and Adjusting Treatment

Regular weight monitoring and clinical follow-up ensure treatment remains appropriate and effective. NICE recommends reviewing response at 6-12 months—if you haven't achieved at least 5% weight loss, your prescriber may adjust the dose, switch medications, or discuss alternative approaches [4].

Blood pressure, heart rate, and blood glucose (particularly in diabetic patients) should be monitored periodically. Some patients experience increased heart rate with GLP-1 medications, typically mild and transient. Report persistent tachycardia, severe abdominal pain, or signs of pancreatitis (severe upper abdominal pain radiating to the back) to your prescriber immediately.

Pricing and Accessing Weight Loss Pens Through Cured Pharmacy

Cured Pharmacy offers transparent upfront pricing visible before you begin your consultation. Mounjaro (tirzepatide) starts from £135.00 per pen, reflecting competitive UK market positioning for this advanced dual-agonist therapy. All prices include the free clinical consultation, electronic prescription, and discreet home delivery with tracking.

We guarantee the lowest prices in the UK for genuine, MHRA-licensed medications sourced exclusively through legitimate UK supply chains. Unlike some providers who display artificially low prices then add consultation fees, delivery charges, or subscription commitments, our pricing is fully inclusive with no hidden costs.

Prescriptions are typically processed within 24 hours of approval, with delivery via Royal Mail or courier depending on your location and urgency. All packaging is plain and discreet with no external indication of contents. If you have questions about dosing, administration, or side effects, our pharmacy team—led by superintendent pharmacist Tarun Kumar—is available via phone (+44 116 4646009) during business hours.

Insurance and NHS Availability

Weight loss medications are available through the NHS under specific criteria, though significant regional variation exists and waiting times can extend to several months. Private prescriptions through registered online pharmacies like Cured provide faster access with greater treatment choice, particularly for newer medications like Mounjaro which may have limited NHS availability.

Some private health insurance policies cover prescription weight loss medications when prescribed for medical rather than cosmetic purposes. Check your policy documents or contact your insurer directly to understand your coverage. Cured Pharmacy provides itemised receipts suitable for insurance claims or flexible spending account reimbursement where applicable.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
  4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and are not guaranteed.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Do I need a prescription to buy weight loss pens online in the UK?
Yes. Mounjaro, Wegovy, and Saxenda are prescription-only medications in the UK and require clinical assessment by a UK-registered prescriber before dispensing. Cured Pharmacy provides a free online consultation as part of the service.
How quickly will I receive my weight loss injection pen after ordering?
Once your prescription is approved by a UK prescriber, orders are typically processed within 24 hours and delivered within 1-3 working days via Royal Mail or courier in discreet packaging.
Can I buy prescription weight loss pens online UK if I'm already taking other medications?
Possibly, depending on the specific medications and your medical history. The online consultation collects information about current medications, and a UK prescriber assesses potential interactions before approving treatment.
What's the difference between Mounjaro and Wegovy for weight loss?
Mounjaro contains tirzepatide (dual GIP/GLP-1 agonist) whilst Wegovy contains semaglutide (GLP-1 agonist only). Clinical trials show tirzepatide produces approximately 40% greater average weight loss, though both are effective options subject to prescriber assessment.
Are weight loss injection pens safe for long-term use?
Clinical trials demonstrate safety profiles up to 72 weeks, with ongoing real-world monitoring continuing beyond that timeframe. Long-term use requires regular clinical supervision to monitor for side effects and assess ongoing appropriateness.
Will I regain weight after stopping weight loss injection pens?
Weight regain is common after discontinuing GLP-1 medications if lifestyle modifications aren't maintained. The STEP-1 trial extension showed participants regained approximately two-thirds of lost weight within one year of stopping semaglutide. Sustainable results require ongoing dietary and activity changes.
Can I buy prescription weight loss pens online UK if I have type 2 diabetes?
Yes, subject to prescriber assessment. Both tirzepatide and semaglutide are licensed for type 2 diabetes management and provide glycaemic control alongside weight loss benefits. Your prescriber will review your diabetes medications and HbA1c levels during consultation.
What if I experience side effects from my weight loss injection pen?
Contact our pharmacy team immediately if you experience severe side effects such as persistent vomiting, severe abdominal pain, or signs of allergic reaction. Mild gastrointestinal effects typically resolve within 4-8 weeks and can be managed with dietary adjustments and adequate hydration.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.